Brief: G1 Therapeutics Provides First Quarter 2024 Results
01/05/2024 11:39
May 1 (Reuters) - G1 Therapeutics Inc GTHX.O :
* G1 THERAPEUTICS PROVIDES FIRST QUARTER 2024 FINANCIAL
RESULTS
AND OPERATIONAL HIGHLIGHTS
* G1 THERAPEUTICS INC: CASH RUNWAY EXPECTED TO EXTEND INTO
Q3 OF
2025
* G1 THERAPEUTICS INC: REAFFIRMED 2024 NET COSELA REVENUE
GUIDANCE
OF $60 TO $70 MILLION
* G1 THERAPEUTICS INC: REAFFIRMED ITS FULL YEAR 2024
FINANCIAL
GUIDANCE
Source text for Eikon: ID:nGNX42T56q
Further company coverage: GTHX.O
Recent news on G1 Therapeutics
See all newsG1 Therapeutics Inc reports results for the quarter ended in June - Earnings Summary
U.S. STOCKS ON THE MOVE-Abbott Laboratories, Medtronic, Axon
U.S. STOCKS ON THE MOVE-Abbott Laboratories, Medtronic, Axon
U.S. STOCKS ON THE MOVE-Ralph Lauren, Illumina, Disney
U.S. STOCKS ON THE MOVE-Walt Disney, SpringWorks, Shopify